Part of Team 8 was present at the ICI (Institute of Cancer and Immunology) congress on April 6.

On this occasion, Aurélie Tchoghandjian presented the PETRA network and Sokhna Babou (Master 2 student) and Emmanuel Snacel-Fazy (PhD student) discussed their results with the scientific community during the poster session.

Team 8 has recently obtained a CMA-CGM funding in the framework of the call for projects "Programme d'équipement et de recherche clinique" 2022

The project title is "Program of Precision RAdioTherapy to Improve patient Cancer treatment" and aims to participate in the purchase of a small animal irradiator "SARRP" that will complement the pre-clinical offerings of the PETRA network.

Team 9 represented by José Luis and team 8 represented by Aurélie Tchoghandjian have obtained Amidex Blanc funding for the project: "Bioinspired cytotoxic copper complexes: deciphering their mechanism of action in cancer cells to develop efficient therapeutic agents (CytoCu4Cancer)".

This project is led by a chemist, Olga Iranzo of the Institute of Molecular Sciences of Marseille (iSm2).

Depuis lundi 3 Avril, l'INP participe à une opération inter-laboratoires de quantification de déchets recyclables professionnels (et ménagers) sur le campus Timone. 
Pour cela, chaque aile a été aménagée avec des points de collecte et de tri sélectif. Chaque semaine, les différentes catégories seront pesées puis emmenées au recyclage pour valorisation. 

Comme chaque année les membres de l'INP participent à la semaine du cerveau. Parmi les actions de cette année on peut citer l'intervention de Cynthia et Charbel deux doctorants de l'équipe 9 qui sont allés rendre visite à l'école primaire du Pharo Catalans

In collaboration with the Holtzman lab., Maud Gratuze, with her colleagues Monica Xiong and Chao Wang, published an article on a project developed during her postdoc in the USA. In this study, entitled "Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy" and recently published in Molecular Neurodegeneration, they reduced ApoE4, the strongest genetic risk factor in Alzheimer’s disease, specifically derived from astrocytes in a mouse model of cerebral amyloid angiopathy.